Cencora, Inc. (COR) Price Target Analysis

Updated Jun 18, 2026

Analyst Rating: Buy

Based on 46 analysts

39.3% Below Target

COR trades 39.3% below Wall Street's consensus target of $378.57.

Current Price$271.83

Average Target$378.57

Target

Current

Low$331.00

Median$360.00

High$440.00

Analyst Target Range

Forward P/E15.3x

(Fair)

PEG Ratio—

Implied Growth+36.3%

(High Growth)

Analyst Spread28.8%

(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$271.83

Consensus$378.57

High$440.00

Low$331.00

Consensus Scenario Assumptions

The base valuation assumes COR achieves its forward estimates and maintains a stable P/E multiple of 15.3x. This scenario reflects the blended consensus of 46 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 46 published analyst recommendations for COR

33/46 analysts are bullish

BearishBullish

Weighted analyst sentiment score based on 46 ratings

ConsensusBuy

Coverage46 Analysts

Net Score+35

Bull / Bear72% / 2%

Strong Buy00%

Buy3372%

Hold1226%

Sell12%

Strong Sell00%

Strong Buy

00%

Buy

3372%

Hold

1226%

Sell

12%

Strong Sell

00%

Recommendation Mix72% Buy · 26% Hold · 2% Sell

Buy (33)Hold (12)Sell (1)

COR Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, Cencora, Inc. (COR) has a Wall Street consensus price target of $378.57, based on estimates from 46 covering analysts. With the stock currently trading at $271.83, this represents a potential upside of +39.3%. The company has a market capitalization of $52.89B.

Analyst price targets range from a low of $331.00 to a high of $440.00, representing a 29% spread in expectations. The median target of $360.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 33 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, COR trades at a trailing P/E of 34.1x and forward P/E of 15.3x. Analysts expect EPS to grow +36.3% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $530.69, with bear and bull scenarios of $334.33 and $699.23 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis

Avg Peer Upside

+81.5%

Industry Consensus

Avg Forward P/E

14.4x

(Value)

Peers with Coverage

9 / 10

Active Analyst Tracking

Company	Market Cap	Price	Target	Upside Potential	Rating	Fwd P/E	Analysts
MCKMcKesson Corporation	$90.2B	$750.63	$994.86	+32.5%	Buy	17.0x	31
CAHCardinal Health, Inc.	$52.2B	$221.77	$253.38	+14.3%	Buy	20.6x	33
OMIOwens & Minor, Inc.	$171M	$2.24	$15.60	+596.4%	Hold	2.3x	10
HSICHenry Schein, Inc.	$9.2B	$79.92	$87.43	+9.4%	Buy	14.9x	33
CVSCVS Health Corporation	$125.4B	$98.32	$103.64	+5.4%	Buy	13.3x	41
PBMPsyence Biomedical Ltd.	$21M	$3.15	—	—	—	—	—
UNHUnitedHealth Group Incorporated	$363.9B	$400.96	$425.81	+6.2%	Buy	21.8x	52
CICigna Corporation	$73.6B	$279.27	$340.91	+22.1%	Buy	9.2x	39
HCAHCA Healthcare, Inc.	$83.9B	$375.17	$504.73	+34.5%	Buy	12.4x	46
DGXQuest Diagnostics Incorporated	$21.6B	$195.00	$220.57	+13.1%	Hold	18.1x	34

COR — Frequently Asked Questions

Quick answers to the most common questions about buying COR stock.

What is the COR stock price target for 2026?

The consensus Wall Street price target for COR is $378.57, representing 39.3% upside from the current price of $271.83. With 46 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is COR a buy, sell, or hold?

COR has a consensus rating of "Buy" based on 46 Wall Street analysts. The rating breakdown is predominantly bullish, with 33 Buy/Strong Buy ratings. The consensus 12-month price target of $378.57 implies 39.3% upside from current levels.

Is COR stock overvalued or undervalued?

With a forward P/E of 15.2921x, COR trades at a relatively low valuation. The consensus target of $378.57 implies 39.3% appreciation, suggesting meaningful undervaluation.

How high can COR stock go?

The most bullish Wall Street analyst has a price target of $440 for COR, while the most conservative target is $331. The consensus of $378.57 represents the median expectation. Our quantitative valuation model projects a bull case target of $699 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover COR stock?

COR is heavily covered by Wall Street, with 46 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 33 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the COR stock forecast?

The 12-month COR stock forecast based on 46 Wall Street analysts shows a consensus price target of $378.57, with estimates ranging from $331 (bear case) to $440 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $531, with bear/bull scenarios of $334/$699.

What is COR's fair value based on fundamentals?

Our quantitative valuation model calculates COR's fair value at $531 (base case), with a bear case of $334 and bull case of $699. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.

What is COR's forward P/E ratio?

COR trades at a forward P/E ratio of 15.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 34.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy COR stock?

Wall Street analysts are very optimistic on COR, with a "Buy" consensus rating and $378.57 price target (39.3% upside). 33 of 46 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do COR price targets vary so much?

COR analyst price targets range from $331 to $440, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $378.57 consensus represents the middle ground. Our model's $334-$699 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools